Canada Spends Logo

Explore our Budget 2026 analysis

Grant: DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)

McGill University

$120,000.00

Implementing decentralized hepatitis C virus (HCV) point-of-care testing for people who inject drugs in Montreal: An evidence synthesis and multi-site process mapping study to inform the development of an implementation blueprint.

FY 2025-26

Summary
Hepatitis C is a serious liver infection affecting over 200,000 people in Canada. It can now be cured in more than 95% of cases with modern medicines, but many people remain undiagnosed or untreated. One of the biggest challenges is that current testing approaches involve several steps and multiple visits, leading to delays and people being lost to follow-up. This is especially true for people who inject drugs, who experience the highest rates of new infections and face barriers such as discrimination. Rapid point-of-care tests can diagnose hepatitis C in an hour and allow people to be diagnosed and linked to care during a single visit. These tests are recommended by the World Health Organization and could transform hepatitis C care, especially in community-based services like needle and syringe programs. However, there is a lack of guidance on how to implement these tests effectively and equitably. This doctoral research will bring together evidence, local expertise and system-level solutions to help close that gap. First, I will synthesize studies from around the world to identify what helps or hinders the use of point-of-care testing for hepatitis C. Second, I will work with several needle and syringe programs in Montreal to understand their readiness for this type of testing and map out how services are currently delivered. Finally, together with community and public health partners, I will co-create a practical plan a step-by-step implementation plan to guide the rollout of hepatitis C point-of-care testing in Montreal and beyond. The impact includes making hepatitis C testing faster, simpler, and more accessible to people who inject drugs. This research will ultimately improve early diagnosis and treatment, reduce the spread of hepatitis C, and advance Canada's goal of eliminating the disease by 2030. It will also promote more equitable health services for people who inject drugs, a population that has often been left behind in mainstream health services.
Program
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
560209
Name
Elakpa Daniel N
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
DT2 (Health services and population health research) CGRS Doctoral
Projecttitle
Implementing decentralized hepatitis C virus (HCV) point-of-care testing for people who inject drugs in Montreal: An evidence synthesis and multi-site process mapping study to inform the development of an implementation blueprint.
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Keyworddelim
Cascade Of Care.; Community-Based Research.; Health Service Research.; Implementation Research.; Knowledge Translation.
Abstract
Hepatitis C is a serious liver infection affecting over 200,000 people in Canada. It can now be cured in more than 95% of cases with modern medicines, but many people remain undiagnosed or untreated. One of the biggest challenges is that current testing approaches involve several steps and multiple visits, leading to delays and people being lost to follow-up. This is especially true for people who inject drugs, who experience the highest rates of new infections and face barriers such as discrimination. Rapid point-of-care tests can diagnose hepatitis C in an hour and allow people to be diagnosed and linked to care during a single visit. These tests are recommended by the World Health Organization and could transform hepatitis C care, especially in community-based services like needle and syringe programs. However, there is a lack of guidance on how to implement these tests effectively and equitably. This doctoral research will bring together evidence, local expertise and system-level solutions to help close that gap. First, I will synthesize studies from around the world to identify what helps or hinders the use of point-of-care testing for hepatitis C. Second, I will work with several needle and syringe programs in Montreal to understand their readiness for this type of testing and map out how services are currently delivered. Finally, together with community and public health partners, I will co-create a practical plan a step-by-step implementation plan to guide the rollout of hepatitis C point-of-care testing in Montreal and beyond. The impact includes making hepatitis C testing faster, simpler, and more accessible to people who inject drugs. This research will ultimately improve early diagnosis and treatment, reduce the spread of hepatitis C, and advance Canada's goal of eliminating the disease by 2030. It will also promote more equitable health services for people who inject drugs, a population that has often been left behind in mainstream health services.
Competitiondate
202511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Elakpa, Daniel N
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~